Evidence map›Paper›PMID 32041557›Full record

ArticleBMC nephrology2020

Validation of pre-operative risk scores of contrast-induced acute kidney injury in a Chinese cohort.

Wenjun Yin, Ge Zhou, Lingyun Zhou, Mancang Liu, Yueliang Xie, Jianglin Wang, Shanru Zuo, Kun Liu, Can Hu, Linhua Chen and 2 more

Open access · goldAbstract readValidation Study
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Wenjun YinDepartment of Pharmacy, The Third Xiangya Hospital of Central South University, Changsha, China.
Ge ZhouDepartment of Pharmacy, The Third Xiangya Hospital of Central South University, Changsha, China.
Lingyun ZhouDepartment of Pharmacy, The Third Xiangya Hospital of Central South University, Changsha, China.
Mancang LiuDepartment of Pharmacy, The Third Xiangya Hospital of Central South University, Changsha, China.
Yueliang XieDepartment of Pharmacy, The Third Xiangya Hospital of Central South University, Changsha, China.
Jianglin WangDepartment of Pharmacy, The Third Xiangya Hospital of Central South University, Changsha, China.
Shanru ZuoDepartment of Pharmacy, The Third Xiangya Hospital of Central South University, Changsha, China.
Kun LiuDepartment of Pharmacy, The Third Xiangya Hospital of Central South University, Changsha, China.
Can HuDepartment of Pharmacy, The Third Xiangya Hospital of Central South University, Changsha, China.
Linhua ChenDepartment of Pharmacy, The Third Xiangya Hospital of Central South University, Changsha, China.
Huiqin YangDepartment of Pharmacy, The Third Xiangya Hospital of Central South University, Changsha, China.
Xiaocong ZuoDepartment of Pharmacy, The Third Xiangya Hospital of Central South University, Changsha, China. zuoxc08@126.com.ORCID 0000-0002-0294-6268
Central South University · CN

Funding

National Natural Science Foundation of China No. 81773822
6 · The paper itself

Abstract

backgroundPre-operative risk scores are more valuable than post-procedure risk scores because of lacking effective treatment for contrast-induced acute kidney injury (CI-AKI). A number of pre-operative risk scores have been developed, but due to lack of effective external validation, most of them are also difficult to apply accurately in clinical practice. It is necessary to review and validate the published pre-operative risk scores for CI-AKI. MATERIALS AND

methodsWe systematically searched PubMed and EMBASE databases for studies of CI-AKI pre-operative risk scores and assessed their calibration and discriminatory in a cohort of 2669 patients undergoing coronary angiography or percutaneous coronary intervention (PCI) from September 2007 to July 2017. The definitions of CI-AKI may affect the validation results, so three definition were included in this study, CI-AKI broad1 was defined as an increase in serum creatinine (Scr) of 44.2 μmol/L or 25%; CI-AKI broad2, an increase in Scr of 44.2 μmol/L or 50%; and CI-AKI-narrow, an increase in Scr of 44.2 μmol/L. The calibration of the model was assessed with the Hosmer-Lemeshow test and the discriminatory capacity was identified by C-statistic.

resultsOf the 8 pre-operative risk scores for CI-AKI identified, 7 were single-center study and only 1 was based on multi-center study. In addition, 7 of the scores were just validated internally and only Chen score was externally validated. In the validation cohort of 2669 patients, the incidence of CI-AKI ranged from 3.0%(Liu) to 16.4%(Chen) for these scores. Furthermore, the incidence of CI-AKI was 6.59% (178) for CI-AKI broad1, 1.44% (39) for CI-AKI broad2, and 0.67% (18) for CI-AKI-narrow. For CI-AKI broads, C-statistics varied from 0.44 to 0.57. For CI-AKI-narrow, the Maioli score had the best discrimination and calibration, what's more, the C-statistics of Maioli, Chen, Liu and Ghani was ≥0.7.

conclusionMost pre-operative risk scores were established based on single-center studies and most of them lacked external validation. For CI-AKI broads, the prediction accuracy of all risk scores was low. The Maioli score had the best discrimination and calibration, when using the CI-AKI-narrow definition.

Indexed as

Preoperative CareAcute Kidney InjuryAgedAged, 80 and overAsian PeopleChinaCohort StudiesContrast MediaCoronary AngiographyCreatinineFemaleHumansMaleMiddle AgedPercutaneous Coronary InterventionRisk AssessmentContrast MediaCreatinineContrast-induced acute kidney injuryContrast mediaCoronary angiographyPercutaneous coronary interventionRisk scores

Identifiers

PMID32041557
PMCPMC7011449
OpenAlexW3009341372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.